| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 07/22/2008 | US7402569 Combining such as sulforaphane with glucosinolate component; economical food additive or dietary supplement |
| 07/22/2008 | US7402563 EPF derived peptides and therapeutic compositions |
| 07/22/2008 | US7402560 oligopeptides capable of stimulating the proliferation or/and the outgrowth from cells presenting the neural cell adhesion molecule (NCAM), used for treatment of normal, degenerated and damaged NCAM presenting cells |
| 07/22/2008 | US7402557 Reducing epithelial toxicity such as a skin rash or diarrhea during cancer therapy, by coadministering KGF with erlotinib (N-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazoline amine) |
| 07/22/2008 | US7402431 T-cell therapy formulation |
| 07/22/2008 | US7402395 Low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 07/22/2008 | US7402388 Using immunophilin (FKBP54) expression as diagnostic/prognostic indicator of cell proliferative disorders; antitumor agents |
| 07/22/2008 | US7402318 Medical devices having antimicrobial coatings thereon |
| 07/22/2008 | US7402309 Phage-associated lytic enzymes for treatment of Bacillus anthracis and related conditions |
| 07/22/2008 | US7402304 human granulocyte colony stimulating factor polypeptides having amino acid replacements in the sequence, used for treating hematopoietic, neurological or reproductive disorders |
| 07/22/2008 | US7402303 Chemokine mutants in the treatment of multiple sclerosis |
| 07/22/2008 | CA2417825C 6.alpha., 9.alpha.-difluoro-17.alpha.-`(2-furanylcarboxyl)oxy!-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflammatory agent |
| 07/22/2008 | CA2388076C Novel substituted succinic acid metallo-beta-lactamase inhibitors and their use in treating bacterial infections |
| 07/22/2008 | CA2280773C Methods for the administration of amifostine |
| 07/22/2008 | CA2278328C Antifungal nail lacquer and method using same |
| 07/22/2008 | CA2248841C Sequential oestrogen/progesterone antagonist combination for hormone replacement therapy |
| 07/22/2008 | CA2238661C Killer t cell activator and use thereof |
| 07/17/2008 | WO2008086483A2 Modulation of neurogenesis with use of modafinil |
| 07/17/2008 | WO2008086400A2 Sirtuin-activating compounds of enhanced bioavailability |
| 07/17/2008 | WO2008086128A2 Aminopyrazole kinase inhibitors |
| 07/17/2008 | WO2008085711A1 Synergy of sodium channel blockers and calcium channel blockers |
| 07/17/2008 | WO2008085392A1 Methods for treating nasal congestion in hepatically impaired patients |
| 07/17/2008 | WO2008085074A2 1, 3-dihydroimidazoles for treating cardiovascular disorders |
| 07/17/2008 | WO2008084710A1 Inhibitor of herpesvirus infection, method for inhibition of herpesvirus infection, and use thereof |
| 07/17/2008 | WO2008084069A1 A method for expanding monocytes |
| 07/17/2008 | WO2008083679A1 Composition for the prevention and treatment of embolism |
| 07/17/2008 | WO2008059197A3 Topical composition comprising an anti- inflammatory steroid and a non-steroidal anti -inflammatory drug |
| 07/17/2008 | WO2008021389A3 Using pi3k and mek modulators in treatments of cancer |
| 07/17/2008 | WO2007116409A3 Improved vaccines comprising multimeric hsp60 peptide carriers |
| 07/17/2008 | US20080171797 Contacting in vivo a mitochondrial NAD-dependent deacetylase polypeptide with test agent in assay mixture of NAD and an acetylated histone peptide; determining effect on the enzymatic activity of mitochondrial NAD-dependent deacetylase; drug screening; diagnosis; anticarcinogenic and antitumor agents |
| 07/17/2008 | US20080171752 5-HT1A Receptor Subtype Agonist |
| 07/17/2008 | US20080171702 Novel gene and uses therefor |
| 07/17/2008 | US20080171691 Inhibition of invasive remodelling |
| 07/17/2008 | US20080171088 Particles of megestrol, megestrol acetate and a surface stabilizer |
| 07/17/2008 | US20080171075 Transdermal composition; amitriptyline, clonidine, ketamine, an anti-inflammatory, lecithin isopropyl palmitate oil; analgesic |
| 07/17/2008 | US20080171054 Immunoglobulin for use in detection, prevention and treatment of methicillin-resistant staphylococcus aureus (MRSA) infection |
| 07/17/2008 | US20080171052 Hmgb1 protein inhibitorsand/or antagonists for the treatment of vascular diseases |
| 07/17/2008 | US20080171051 Cancer Treatment |
| 07/17/2008 | US20080171050 Treatment of hyperproliferative diseases with epidermal growth factor receptor antagonists |
| 07/17/2008 | US20080171049 For prophylaxis and therapy of hemorrhagic virus infection, autoimmune diseases, autograft rejection, neoplasm, hyperhomocysteineuria, cardiovascular disease, stroke, Alzheimer's disease, or diabetes; can be used in combination with an anti-hemorrhagic viral infection agent, an immunosuppressant; kits |
| 07/17/2008 | US20080171021 Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation |
| 07/17/2008 | US20080171017 Therapeutic mixture comprising chimeric interleukin receptor, microbiocidal, antiproliferative and chemotherapeutic agent for use in treatment and prevention of infectious and cancer disorders |
| 07/17/2008 | DE60130743T2 Mikrokugeln zur aktiven embolisierung Microspheres for embolization active |
| 07/17/2008 | DE102007001804A1 Verwendung von GABAB-Rezeptor selektiven Agonisten zur Behandlung entzündlicher Hauterkrankungen Use of GABAB receptor selective agonist for the treatment of inflammatory skin diseases |
| 07/17/2008 | CA2675132A1 Modulation of neurogenesis with use of modafinil |
| 07/17/2008 | CA2674305A1 Therapy |
| 07/17/2008 | CA2618691A1 Methods for preventing, managing, and reversing disease caused by inflammation mediated vascular lesions |
| 07/16/2008 | EP1944361A1 A method for expanding monocytes |
| 07/16/2008 | EP1944300A2 Prodrugs of aspartyl protease inhibitors |
| 07/16/2008 | EP1944042A1 Combinations for HCV treatment |
| 07/16/2008 | EP1944041A1 Therapeutic agent for neurogenic pain |
| 07/16/2008 | EP1944026A2 Use of EDG receptor binding agents in cancer |
| 07/16/2008 | EP1944019A2 Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof |
| 07/16/2008 | EP1942938A1 Use of oligouronates for treating mucus hyperviscosity |
| 07/16/2008 | EP1942916A1 Agent for protecting body cells |
| 07/16/2008 | EP1942909A2 Methods for treating respiratory disorders |
| 07/16/2008 | EP1499325B1 Composition comprising trehalose and zinc and use thereof to inhibit skin irritation |
| 07/16/2008 | EP1485160B1 Intraductal management of breast lesions involving therapeutic or diagnostic agents |
| 07/16/2008 | EP1471907B1 Use of c-kit inhibitors for treating autoimmune diseases |
| 07/16/2008 | EP1461032B1 Use of c-kit inhibitors for promoting hair growth |
| 07/16/2008 | EP1446104B1 Spray drying methods |
| 07/16/2008 | EP1426051B1 Medicinal composition for prevention of or treatment for cerebrovascular disorder |
| 07/16/2008 | EP1392264B1 Delivery of antiemetics through an inhalation route |
| 07/16/2008 | EP1392257B1 Delivery of antihistamines through an inhalation route |
| 07/16/2008 | EP1337270B1 Long-acting interferon and interlukin derivatives and pharmaceutical compositions comprising them |
| 07/16/2008 | EP1305006B1 Process for the manufacture of dispersions for formulating slightly or poorly soluble active ingredients |
| 07/16/2008 | EP1294383B1 Oral compositions comprising antimicrobial agents for the prevention of systemic diseases |
| 07/16/2008 | EP1294367B1 Oral compositions comprising host-response modulating agent |
| 07/16/2008 | EP1051479B1 Novel steroid-activated nuclear receptors and uses therefor |
| 07/16/2008 | EP0630246B1 Estrogen/progestin/antiprogestin method and kit for oral contraception and regulating menses |
| 07/16/2008 | CN101222938A Use of inhibitors of histone deacetylases in combination with NASAID for the therapy of cancer and/or inflammatory diseases |
| 07/16/2008 | CN101222919A Combination of a DPP-iv inhibitor and a cannabinoid CB1 receptor antagonist |
| 07/16/2008 | CN101222912A Novel pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative |
| 07/16/2008 | CN101219156A Externally used drug for treating condyloma acuminata and genitalia herpes |
| 07/16/2008 | CN101219148A Beta-d-2', 3' -didehydro-2', 3' -dideoxy-5-fluorocytidine for use in the treatment of HIV infections |
| 07/16/2008 | CN101219111A Anticancer injection containing bendamustine and its potentiating agent |
| 07/16/2008 | CN101219108A Drug delivery of phase changing formulation |
| 07/16/2008 | CN100402549C Bridged bicyclic serine protease inhibitors |
| 07/16/2008 | CN100402510C Oxazole derivatives and their use as insulin sensitizers |
| 07/16/2008 | CN100402091C Anticarcinogen composition |
| 07/16/2008 | CN100402042C Composition and method for augmenting kidney function |
| 07/16/2008 | CN100402029C Combinations comprising epothilone derivatives and alkylating agent |
| 07/16/2008 | CN100402026C Use of substituted cyanopyrrolidines and combination preparations containing them for treating hyperlipidemia and associated diseases |
| 07/16/2008 | CN100402017C Esters of l-carnitine of alkanoyl l-carnitines useful as cationic lipids for the intracellular delivery of pharmacologically active compounds |
| 07/15/2008 | US7399901 linker for activation of T- cells (lat genes and proteins), used for screening drug useful for treatment against asthma and allergies |
| 07/15/2008 | US7399827 For diagnosis and for vaccine based therapy of neoplasms of prostate, testis and uterus; inhibiting the growth of malignant cells expressing PAGE-4, and methods of inducing an enhanced immune response to PAGE-4-expressing cancers |
| 07/15/2008 | US7399772 Substituted benzimidazole dosage forms and method of using same |
| 07/15/2008 | US7399764 N-ethyl-N'-{(3R)-1-[4-(3-phenylthieno[3,4-b]pyrazin-2-yl)benzyl]pyrrolidin-3-yl}urea; inhibit activity of a serine, threonine protein kinase; cancer |
| 07/15/2008 | US7399741 Notch |
| 07/15/2008 | US7399605 Generating preferential polymerase in sample; obtain nucleotide sequences, incubate in reaction mixture, translate nucleotide sequences, recover polypeptide |
| 07/15/2008 | US7399595 Means for the diagnosis and therapy of CTCL |
| 07/15/2008 | US7399583 Mixing the HuR protein and the ARE-containing mRNA in the presence of the candidate inhibitor and in the absence of the candidate inhibitor; detecting and comparing the amount of complexes with the non-complexed mRNA/protein species; identifying a candidate inhibitor |
| 07/15/2008 | US7399492 Composition and method for issue repair and regeneration |
| 07/15/2008 | US7399485 Rapidly Disintegrable solid preparation |
| 07/15/2008 | US7399466 Osteocalcin; enzyme inhibitors; promote bone, teeth growth; administering Dna gene |
| 07/15/2008 | US7399463 HSA-free formulations of interferon-beta |
| 07/15/2008 | CA2425560C Anticholinergics, processes for preparing them and their use as pharmaceutical compositions |
| 07/15/2008 | CA2407606C Bis-(n,n'-bis-(2-haloethyl)amino) phosphoramidates as antitumor agents |
| 07/15/2008 | CA2378892C Preserved pharmaceutical formulations |
| 07/15/2008 | CA2334411C Use of a composition comprising formoterol and budesonide for the prevention or treatment of an acute condition of asthma |